Canadian Partnership Against Cancer
 

 
ENGLISH  |  FRANÇAIS
 
 
SHARE: twt fb yt
 
 
JUNE/JULY 2016
 
IN BRIEF
 
THE PARTNERSHIP THANKS OUTGOING CHAIR CHRIS POWER
 
The Canadian Partnership Against Cancer is thanking outgoing Chair Chris Power for seven years of service on the Board of Directors and her leadership in implementing Canada's cancer strategy.

Under Ms. Power's leadership, the Partnership released We See Progress, the 2017-2022 strategic plan, and received ongoing funding to implement the next phase of Canada's cancer strategy. The Partnership is grateful for Ms. Power's many contributions to reducing the burden of cancer on Canadians.
Dr. Graham Sher takes over the role of Chair from Ms. Power effective June 21, 2016. Dr. Sher joined the Partnership's Board in June 2012 and has served as Vice Chair since June 2014.

The Partnership wishes Ms. Power all the best for the future and welcomes Dr. Sher to his new role as Board Chair.

Read More
 
 
 
 
 
 
LOW-INCOME CANCER PATIENTS LESS LIKELY TO SURVIVE
 
Lower-income cancer patients are less likely to survive the disease, according to new research from the Canadian Partnership Against Cancer's annual cancer system performance report, suggesting they may not receive the same care as wealthier patients.

For the first time, researchers were able to analyze cancer survival rates for breast, lung, colorectal and prostate cancers while removing the effect of other health risks.

The difference in survival rates – a 10 per cent relative change in the case of colorectal cancer – suggests lower-income patients are not receiving equitable care. Lower-income individuals may not be screened for cancer, have symptoms recognized early or receive the most effective treatment.
 
Read More
 
 
 
 
 
 
MACLEAN'S HIGHLIGHTS HOW DATA IMPROVE CANADIAN CANCER CARE
 
A special supplement on innovations in cancer appearing in a recent edition of Maclean's magazine contains an article highlighting how the Partnership's data collection through efforts like electronic synoptic reporting and cancer system performance reporting is making a difference to cancer patients.

The article quotes Partnership CEO Shelly Jamieson and Dr. Geoff Porter, Expert Lead in Clinical Care, both speaking about how reporting on indicators through our cancer system performance report has helped to ensure guidelines are closely followed when removing and analyzing lymph nodes, which can help determine whether a cancer has spread.

When the Partnership first began monitoring concordance with guidelines recommending the removal of 12 or more lymph nodes in colon cancer surgeries, the guideline was followed in as few as 56% of surgeries in some jurisdictions. Today, that number has grown in excess of 90% of surgeries in some provinces.
 
Read More
 
 
 
 
 
 
PAN-CANADIAN STUDY AIMS TO IMPROVE TRANSITIONS IN CARE
 
When cancer treatment ends, patients and survivors transition from specialty oncology care back to their family doctor. This transition is often met with questions about what happens next, what changes, and where to go to seek help. The Canadian Partnership Against Cancer is conducting the Experiences of Cancer Patients in Transition study in collaboration with provinces across the country to help inform recommendations to improve the way care is provided between cancer care and other sectors of the health care system providing follow-up and supportive care.
 
Read More
 
 
 
 
 
NOW AVAILABLE: UPDATED SMOKING CESSATION RESOURCES
 
The Partnership recently updated two smoking cessation resources available on cancerview.ca.

The Leading Practices in Clinical Smoking Cessation Program Scan provides information on current practices in clinical smoking cessation across Canada by province and territory. It provides information to help practitioners and policy specialists learn from each other and improve their current practices in tobacco cessation.

The Leading Practices in First Nations, Inuit and Métis Smoking Cessation Program Scan provides information on smoking cessation programs developed by, with and for First Nations, Inuit and Métis across Canada by jurisdiction.
 
Read More
 
 
 
 
 
 
Canadian Partnership Against Cancer
1 ‌University Ave. Suite 30‌0 Toronto, Ontario M5‌J 2P‌1 Canada
 
 
 
 
Unsubscribe  |  Privacy policy  |  Subscribe

Production of this publication has been made possible through a financial contribution from
Health Canada, through the Canadian Partnership Against Cancer. The views expressed herein
represent the views of the Canadian Partnership Against Cancer.
 
CANADIAN PARTNERSHIP AGAINST CANCER